A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tannaz Armaghany, MD
Baylor College of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Baylor College of Medicine
Houston, Texas, United States
- Baylor College of Medicine Medical Center - Mcnair Campus
Houston, Texas, United States
- Baylor St. Luke'S Medical Center
Houston, Texas, United States
- Ben Taub Hospital
Houston, Texas, United States
- Harris Health System- Smith Clinic
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Mar 2024
- Primary completion
- 20 Feb 2025
- Completion
- 20 Feb 2025
- Last update posted
- 9 Apr 2026
- Registered enrollment
- 3
- Registry id
- NCT05567835
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.